Lihi Schwartz/LinkedIn
Oct 28, 2025, 06:45
Lihi Schwartz Presented Efficacy and Safety of Anticoagulation for Subsegmental Pulmonary Embolism
Lihi Schwartz, Family Medicine Resident at Clalit Health Services, shared a post on LinkedIn:
“Today, I had the privilege of presenting our systematic review and meta-analysis; “Efficacy and Safety of Anticoagulation for Subsegmental Pulmonary Embolism (SSPE)”, at the Annual Conference of the Family Medicine Department, Clalit Health Services.
We explored the routine use of anticoagulation in SSPE — a setting where the true benefit remains uncertain — and reflected on the importance of avoiding overtreatment.
Grateful for the opportunity to share insights and promote thoughtful, evidence-based care.”
Stay updated with Hemostasis Today.
-
Oct 9, 2026, 11:06Nobles Green: How siRNA Therapy Helps the Body Form Stronger Clots
-
Oct 9, 2026, 10:53Switching From Emicizumab to Denecimig in Hemophilia A – Rare Disease Advisor
-
Oct 9, 2026, 10:40What New U.S. Data Reveal About GT – Glanzmann’s Research Foundation
-
Oct 9, 2026, 10:32Anjali Pandey: The Morphologic Clues to MDS With del(5q)
-
Oct 9, 2026, 10:13Reza Shojaei: 5 Leadership Responsibilities for a Sustainable Plasma Ecosystem
-
Oct 9, 2026, 08:38Johannes Gratz: Perioperative Care in Factor VII Deficiency – Treating the Patient, Not the Number
-
Oct 9, 2026, 08:28Ghanim Fajish: Vascular Cells May Retain a Prothrombotic Memory of Oxidative Stress
-
Oct 9, 2026, 07:43Mehmet Cilingiroglu: The First Diagnosis of Coronary Thrombosis in a Living Patient
-
Oct 9, 2026, 07:21Federico Ravaioli: 40 kPa Spleen Stiffness May Help Avoid Endoscopy in Chronic PVT